Phibro Animal Health (PAHC) Tops Q4 EPS by 8c, provides guidance

Phibro Animal Health (NASDAQ: PAHC) reported Q4 EPS of $0.41, $0.08 better than the analyst estimate of $0.33. Revenue for the quarter came in at $273.2 million versus the consensus estimate of $260.49 million.

GUIDANCE:

Phibro Animal Health sees FY2025 EPS of $1.22-$1.37, versus the consensus of $1.24. Phibro Animal Health sees FY2025 revenue of $1.04-1.09 billion, versus the consensus of $1.029 billion.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

You May Also Be Interested In

• GameStop CEO Cohen buys 1.15M shares
• Lilly breaks ground on $6.5B Houston drug manufacturing site
• Wabtec signs $700M rail services deal for Guinea mining project